Return
DLX2 drives vascular calcification in chronic kidney disease through glycolytic activation: a mechanism epigenetically regulated by HDAC2
Q
P
Z
G
DOI:10.1016/j.intimp.2026.117025.png)
Abstract
En 中文
• HDAC2 epigenetically silences DLX2 by reducing H3K9ac at its promoter. • DLX2 knockdown attenuates VSMC calcification and glycolysis in vitro and in vivo. • The pro-calcific effect of DLX2 is mediated via WNT1/β-catenin-glycolysis axis.
Journal
IF:
4.7
Papers:
1.6W
Citations:
4.1W
